MCID: VSL003
MIFTS: 40

Visual Agnosia

Categories: Eye diseases, Mental diseases

Aliases & Classifications for Visual Agnosia

MalaCards integrated aliases for Visual Agnosia:

Name: Visual Agnosia 12 15
Primary Visual Agnosia 45 74

Classifications:



External Ids:

Disease Ontology 12 DOID:0060155
MeSH 45 C531604
UMLS 74 C2930796

Summaries for Visual Agnosia

Disease Ontology : 12 An agnosia that is a loss of the ability to visually recognize objects.

MalaCards based summary : Visual Agnosia, also known as primary visual agnosia, is related to alexia and agnosia. An important gene associated with Visual Agnosia is MRI1 (Methylthioribose-1-Phosphate Isomerase 1), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Alzheimers Disease Pathway. The drugs Dexmedetomidine and Dezocine have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and temporal lobe.

Wikipedia : 77 Visual agnosia is an impairment in recognition of visually presented objects. It is not due to a deficit... more...

Related Diseases for Visual Agnosia

Diseases related to Visual Agnosia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 73)
# Related Disease Score Top Affiliating Genes
1 alexia 30.8 KANTR PSEN1
2 agnosia 12.2
3 kluver-bucy syndrome 11.1
4 spastic paraplegia 14 11.1
5 alzheimer disease 4 10.4 PSEN1 PSEN2
6 early-onset, autosomal dominant alzheimer disease 10.4 PSEN1 PSEN2
7 mesenteric vascular occlusion 10.3 F7 MB
8 prosopagnosia 10.3
9 olfactory groove meningioma 10.3 F7 SYP
10 spinal cord melanoma 10.3 MRI1 SMUG1
11 orbital cancer 10.2 MB SYP
12 rhabdoid cancer 10.2 MB SYP
13 angiomyoma 10.2 MB SYP
14 thymus lipoma 10.2 MB SYP
15 substernal goiter 10.2 F7 KANTR
16 myxosarcoma 10.2 MB SYP
17 immune system organ benign neoplasm 10.2 MB SYP
18 internuclear ophthalmoplegia 10.2 KANTR PSEN1
19 mixed cell type cancer 10.2 MB SYP
20 partial motor epilepsy 10.2 SMUG1 SYP
21 cellular ependymoma 10.2 SMUG1 SYP
22 posterior myocardial infarction 10.2 KANTR MB
23 alzheimer disease 10.2
24 gastrointestinal neuroendocrine tumor 10.2 SMUG1 SYP
25 subendocardial myocardial infarction 10.2 KANTR MB
26 gallbladder small cell carcinoma 10.2 SMUG1 SYP
27 thyroid crisis 10.2 KANTR MB
28 mediastinal cancer 10.2 SMUG1 SYP
29 postencephalitic parkinson disease 10.1 KANTR SYP
30 agraphia 10.1 KANTR PSEN1
31 cardiovascular organ benign neoplasm 10.1 KANTR MB
32 malignant skin fibrous histiocytoma 10.1 F7 SMUG1
33 plexopathy 10.1 MB SMUG1
34 abducens nerve disease 10.1 KANTR SYP
35 functional colonic disease 10.1 KANTR SYP
36 benign perivascular tumor 10.1 KANTR MB
37 intraocular retinoblastoma 10.1 KANTR SYP
38 radiation cystitis 10.1 F7 KANTR
39 pericardium cancer 10.1 MB SMUG1
40 familial isolated dilated cardiomyopathy 10.1 PSEN1 PSEN2
41 oculomotor nerve paralysis 10.1 KANTR SMUG1
42 punctate epithelial keratoconjunctivitis 10.1 KANTR PSEN2
43 third cranial nerve disease 10.1 KANTR SMUG1
44 transient global amnesia 10.1 KANTR PSEN1
45 medullomyoblastoma 10.1 MB SYP
46 autism 10.1
47 aphasia 10.1
48 alzheimer disease 2 10.1 PSEN1 PSEN2 SMUG1
49 apperceptive agnosia 10.1 PSEN1 TOR3A
50 malignant dermis tumor 10.1 F7 SMUG1

Graphical network of the top 20 diseases related to Visual Agnosia:



Diseases related to Visual Agnosia

Symptoms & Phenotypes for Visual Agnosia

Drugs & Therapeutics for Visual Agnosia

Drugs for Visual Agnosia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 110)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
2
Dezocine Approved, Investigational Phase 4 53648-55-8 40841 3033053
3
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
4
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
5
Nalbuphine Approved Phase 4 20594-83-6 5360630 5311304
6
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 137-58-6 3676
7
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 57-27-2 5288826
8
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
9
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
10
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Not Applicable 50-02-2 5743
11
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Not Applicable 1177-87-3
12
Levobupivacaine Approved, Investigational Phase 4,Not Applicable 27262-47-1 92253
13
Sufentanil Approved, Investigational Phase 4,Not Applicable 56030-54-7 41693
14
Ropivacaine Approved Phase 4,Phase 3,Not Applicable 84057-95-4 71273 175805
15
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
16
Nefopam Approved, Investigational Phase 4 13669-70-0
17
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
18
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
19
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
20
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
21
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
22
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
23
Clonidine Approved Phase 4 4205-90-7 2803
24
Tramadol Approved, Investigational Phase 4,Phase 3 27203-92-5 33741
25 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
26 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
27 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Not Applicable
28 Anti-Inflammatory Agents Phase 4,Not Applicable
29 Adrenergic Agonists Phase 4,Not Applicable
30 Cyclooxygenase Inhibitors Phase 4,Not Applicable
31 Adrenergic alpha-2 Receptor Agonists Phase 4,Not Applicable
32 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Not Applicable
33 Neurotransmitter Agents Phase 4,Not Applicable
34 Narcotics Phase 4,Phase 2,Phase 3,Not Applicable
35 Adrenergic alpha-Agonists Phase 4,Not Applicable
36 Adrenergic Agents Phase 4,Not Applicable
37 Analgesics Phase 4,Phase 2,Phase 3,Not Applicable
38 Antirheumatic Agents Phase 4,Not Applicable
39 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Not Applicable
40 Hypnotics and Sedatives Phase 4,Phase 3,Not Applicable
41 Excitatory Amino Acids Phase 4,Not Applicable
42 Anesthetics, General Phase 4,Phase 3,Not Applicable
43 Anesthetics, Intravenous Phase 4,Phase 3,Not Applicable
44 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
45 Anesthetics, Dissociative Phase 4
46 Excitatory Amino Acid Antagonists Phase 4,Not Applicable
47 Anesthetics, Local Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
48 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
49 Sodium Channel Blockers Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
50 Diuretics, Potassium Sparing Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 71)
# Name Status NCT ID Phase Drugs
1 Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia Unknown status NCT03014713 Phase 4 Dezocine;Flubiprofen;Dexmedetomidine
2 Ketamine and Postoperative Analgesia in Children Unknown status NCT00200564 Phase 4 ketamine
3 Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections Recruiting NCT03105193 Phase 4 IV Saline bolus and infusion;IP Saline bolus and infusion;IV lignocaine bolus and infusion;IP Lignocaine bolus and infusion
4 Dexmedetomidine Supplemented Analgesia and 2-Year Survival After Cancer Surgery Recruiting NCT03012971 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
5 Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery. Completed NCT03007121 Phase 4 Morphine intrathecal;Bupivacaine + Sufentanil epidural;Morphine intravenous
6 Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks Completed NCT02523235 Phase 4 ropivacaine 0.2%
7 Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. Terminated NCT01882530 Phase 4 Paracetamol;Nefopam;Ketoprofen;Morphine
8 The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia Completed NCT00800826 Phase 4 dexmedetomidine
9 A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. Terminated NCT00421720 Phase 4 Sufentanil;Remifentanil
10 Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery Recruiting NCT03629262 Phase 4 Dexmedetomidine;Placebo
11 Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia Completed NCT02516059 Phase 4 oxycodone/naloxone;Oxycodone;Placebo
12 Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery Completed NCT01966172 Phase 4 Ibuprofen;Gabapentin;Morphine;Paracetamol
13 Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine Completed NCT00860899 Phase 4 clonidine, levobupivacaine
14 Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy Completed NCT00564603 Phase 4 Dexamethasone Sodium Phosphate Injection
15 Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium Recruiting NCT03012984 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
16 A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia Unknown status NCT02811991 Phase 2, Phase 3 Paracetamol injection;Normal Saline injection;Morhpine PCA
17 Combination Analgesia for Neonatal Circumcision Completed NCT02990364 Phase 3 Sucrose;Lidocaine;EMLA Topical Product
18 Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia Completed NCT02264821 Phase 3 ropivacaine infiltration;intrathecal morphine;placebo
19 Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants Completed NCT00713726 Phase 3 FentanyL;Tramadol
20 Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) Terminated NCT00436345 Phase 3 Remifentanil;Propofol
21 Continuous Regional Analgesia After Total Knee Arthroplasty Completed NCT00337597 Phase 3
22 Development of a New Method for Analgesia Completed NCT00791024 Phase 1, Phase 2 CRC-Pharma 001;lidocaine suspension
23 Protective Analgesia in Caesarean Section Using Intravenous Paracetamol Unknown status NCT03060265 Not Applicable Paracetamol;PLACEBO
24 Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia Unknown status NCT01739270 Not Applicable
25 Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients Unknown status NCT01553435 Not Applicable Dextromethorphan;Placebo
26 Do Epidurals Placed at a Lower Level Improve Labor Analgesia? Unknown status NCT00954317 Not Applicable
27 Depodur vs Fentanyl Infusion for Post-C/S Analgesia Unknown status NCT00762554 Not Applicable Depodur;Depodur;Fentanyl
28 Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia Unknown status NCT01097499 Not Applicable
29 Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AF Unknown status NCT01718717 Not Applicable
30 Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population. Unknown status NCT01817101 Not Applicable
31 Perception and Multisensory Integration in Neurological Patients Using fMRI Unknown status NCT01469858 Not Applicable
32 Orientation Agnosia: Clinical and Anatomical Study Completed NCT01304576 Not Applicable
33 Comparative Study of the Combination of Different Modes of Administration of Local Anesthetics in Labor Analgesia Recruiting NCT03839056
34 A Comparison of Sedation/Analgesia & LMA on Anxiety Level and Patient Satisfaction in In-Vitro Fertilization Enrolling by invitation NCT03814330 Not Applicable
35 TAP vs Caudal Block Using Dexmedetomidine/ Bupivacaine for Post Operative Analgesia Recruiting NCT03482947 Not Applicable ultrasonography-guided TAP block;Caudal epidural block
36 Newborn Cortical Response to Pain and Non Pharmacological Analgesia Completed NCT03389789 Not Applicable
37 Comparison of Labor Analgesia Between Modified Combined Spinal-Epidural and Dural Puncture Epidural Techniques Not yet recruiting NCT03258879 Not Applicable
38 Comparison of Patient-Controlled Analgesia With Different Background Infusion Completed NCT03221491 Not Applicable
39 Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT03203967 Not Applicable Intravenous morphine analgesia
40 Impact of Preemptive Intravenous Ibuprofen on Intraoperative Analgesia in Third Molar Teeth Active, not recruiting NCT03170726 Not Applicable arveles;intrafen 800 mg
41 Pulse Pressure Variability With Position Before EPIdural Analgesia Recruiting NCT03126136 Not Applicable
42 Perfusion Index and Labor Analgesia Recruiting NCT03107559
43 Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy Completed NCT02990910 Not Applicable personalized opioid analgesia
44 A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT02104934 Not Applicable
45 μ-opioid Receptor Polymorphism and Opioid Analgesia Completed NCT02099877 Fentanyl
46 The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers Completed NCT01886014 Not Applicable Oxytocin
47 Labour Analgesia and Movement in Babies Completed NCT01280084
48 The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT) Completed NCT01261689 Not Applicable Ropivacaine/ Sufentanil according to local hospital protocol
49 Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia Completed NCT00487084 Not Applicable Morphine-CP-saline (MCS);saline-2CP-morphine (SCM);saline-lidocaine-morphine (SLM)
50 Changes in Sensitivity, Taste and Smell in Stroke Patients Recruiting NCT03240965

Search NIH Clinical Center for Visual Agnosia

Cochrane evidence based reviews: primary visual agnosia

Genetic Tests for Visual Agnosia

Anatomical Context for Visual Agnosia

MalaCards organs/tissues related to Visual Agnosia:

42
Brain, Cortex, Temporal Lobe, Colon, Eye

Publications for Visual Agnosia

Articles related to Visual Agnosia:

(show top 50) (show all 118)
# Title Authors Year
1
The neuropsychological rehabilitation of visual agnosia and Balint's syndrome. ( 29366371 )
2018
2
The contribution of facial dynamics to subtle expression recognition in typical viewers and developmental visual agnosia. ( 29723598 )
2018
3
Visual agnosia and focal brain injury. ( 28843416 )
2017
4
Preserved Expert Object Recognition in a Case of Unilateral Visual Agnosia. ( 28949822 )
2017
5
Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign. ( 27821572 )
2016
6
Visual agnosia. ( 26358494 )
2015
7
Making memories: the development of long-term visual knowledge in children with visual agnosia. ( 24319599 )
2013
8
Configural Gestalts remain nothing more than the sum of their parts in visual agnosia. ( 25165506 )
2013
9
The right place at the right time: priming facial expressions with emotional face components in developmental visual agnosia. ( 22349446 )
2012
10
Selective impairment of living things and musical instruments on a verbal 'Semantic Knowledge Questionnaire' in a case of apperceptive visual agnosia. ( 22771855 )
2012
11
Eye movements during object recognition in visual agnosia. ( 22627025 )
2012
12
Visual agnosia and posterior cerebral artery infarcts: an anatomical-clinical study. ( 22276198 )
2012
13
Visual agnosia. ( 23144207 )
2012
14
Perception of biological motion in visual agnosia. ( 22973210 )
2012
15
Impaired integration of emotional faces and affective body context in a rare case of developmental visual agnosia. ( 21482423 )
2012
16
Psychic blindness or visual agnosia: early descriptions of a nervous disorder. ( 21253940 )
2011
17
Modeling eye movements in visual agnosia with a saliency map approach: bottom-up guidance or top-down strategy? ( 21316191 )
2011
18
Development of a vocabulary of object shapes in a child with a very-early-acquired visual agnosia: a unique case. ( 20680887 )
2011
19
Separate processing of texture and form in the ventral stream: evidence from FMRI and visual agnosia. ( 19478035 )
2010
20
Visual agnosia for line drawings and silhouettes without apparent impairment of real-object recognition: a case report. ( 19996516 )
2009
21
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia. ( 19184324 )
2009
22
Fixation and saliency during search of natural scenes: the case of visual agnosia. ( 19428433 )
2009
23
To know what it is for, but not how it is: semantic dissociations in a case of visual agnosia. ( 18704832 )
2008
24
Associative visual agnosia: a case study. ( 18413915 )
2008
25
Chapter 21 Visual agnosia. ( 18631704 )
2008
26
Implicit integration in a case of integrative visual agnosia. ( 17339044 )
2007
27
Impairments in part-whole representations of objects in two cases of integrative visual agnosia. ( 18066732 )
2007
28
[Apperceptive form visual agnosia caused by anti-TNFalpha therapy to rheumatoid arthritis]. ( 17511276 )
2007
29
Visual agnosia and prosopagnosia secondary to melanoma metastases: case report. ( 29213375 )
2007
30
No double-dissociation between optic ataxia and visual agnosia: multiple sub-streams for multiple visuo-manual integrations. ( 16753188 )
2006
31
A two-stage account of computing and binding occluded and visible contours: Evidence from visual agnosia and effects of lorazepam. ( 21049331 )
2006
32
The role of sensory-motor information in object recognition: evidence from category-specific visual agnosia. ( 15896389 )
2005
33
Behavioral change and its neural correlates in visual agnosia after expertise training. ( 15829077 )
2005
34
Visuomotor performance in a patient with visual agnosia due to an early lesion. ( 15130585 )
2004
35
2D but not 3D: pictorial-depth deficits in a case of visual agnosia. ( 15505981 )
2004
36
Electrophysiological correlates of associative visual agnosia lesioned in the ventral pathway. ( 15178214 )
2004
37
Radical "visual capture" observed in a patient with severe visual agnosia. ( 12719638 )
2003
38
Category-specific visual agnosia: lesion to semantic memory versus extra-lesional variables in a case study and a connectionist model. ( 14642293 )
2003
39
Visual agnosia. ( 12916489 )
2003
40
What does visual agnosia tell us about perceptual organization and its relationship to object perception? ( 12669745 )
2003
41
Visual agnosia in a child with non-lesional occipito-temporal CSWS. ( 12767457 )
2003
42
Implicit face perception in a patient with visual agnosia? Evidence from behavioural and eye-tracking analyses. ( 12591027 )
2003
43
Visual agnosia. ( 14565906 )
2003
44
A Case Study of Visual Agnosia without Perceptual Processing or Structural Descriptions Impairment. ( 20957586 )
2003
45
Visual agnosia and prosopagnosia in childhood: a prospective case study. ( 12610772 )
2002
46
The role of premorbid expertise on object identification in a patient with category-specific visual agnosia. ( 20957546 )
2002
47
Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl. ( 11575616 )
2001
48
Visual agnosia and KlA1ver-Bucy syndrome in marmosets (Callithrix jacchus) following ablation of inferotemporal cortex, with additional mnemonic effects of immunotoxic lesions of cholinergic projections to medial temporal areas. ( 11292457 )
2001
49
Animals and artifacts may not be treated equally: differentiating strong and weak forms of category-specific visual agnosia. ( 11237370 )
2001
50
Early onset epileptic auditory and visual agnosia with spontaneous recovery associated with Tourette's syndrome. ( 11561053 )
2001

Variations for Visual Agnosia

Expression for Visual Agnosia

Search GEO for disease gene expression data for Visual Agnosia.

Pathways for Visual Agnosia

Pathways related to Visual Agnosia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.69 CYLD PSEN1 PSEN2
2 10.97 PSEN1 PSEN2
3 10.59 PSEN1 PSEN2
4 10.32 PSEN1 PSEN2
5 9.32 PSEN1 PSEN2

GO Terms for Visual Agnosia

Biological processes related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 proteolysis GO:0006508 9.76 CYLD F7 PSEN1 PSEN2
2 response to hypoxia GO:0001666 9.61 F7 MB PSEN2
3 membrane protein ectodomain proteolysis GO:0006509 9.4 PSEN1 PSEN2
4 regulation of protein binding GO:0043393 9.37 CYLD PSEN1
5 amyloid-beta metabolic process GO:0050435 9.32 PSEN1 PSEN2
6 Notch receptor processing GO:0007220 9.26 PSEN1 PSEN2
7 amyloid precursor protein catabolic process GO:0042987 9.16 PSEN1 PSEN2
8 Notch receptor processing, ligand-dependent GO:0035333 8.96 PSEN1 PSEN2
9 protein processing GO:0016485 8.8 F7 PSEN1 PSEN2

Molecular functions related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidase activity GO:0008233 9.56 CYLD F7 PSEN1 PSEN2
2 aspartic-type endopeptidase activity GO:0004190 9.16 PSEN1 PSEN2
3 endopeptidase activity GO:0004175 9.13 F7 PSEN1 PSEN2
4 aspartic endopeptidase activity, intramembrane cleaving GO:0042500 8.62 PSEN1 PSEN2

Sources for Visual Agnosia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....